Skip to main content

Advertisement

Log in

Follow-up of age-related macular degeneration patients treated by photodynamic therapy with optical coherence tomography 3

  • Clinical Investigation
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract

Background

Photodynamic therapy (PDT) has been described to effectively reduce or delay severe vision loss in eyes with predominantly classic form of choroidal neovascularization (CNV) due to age-related macular degeneration (AMD). Optical coherence tomography 3 (OCT3) is a non-invasive diagnostic procedure which provides information about retinal thickness and volume at the posterior pole, as well as about the presence of certain structures under the retina.

Methods

Prospective interventional study. Eleven eyes (9 patients) with AMD and CNV were treated with Verteporfin PDT. A complete ophthalmologic examination was performed. Fluorescein angiography (FA) and OCT3 scans were performed before treatment and 1, 2, 4, and 12 weeks after it.

Results

Two different patterns of changes were observed. One group (7 eyes) showed changes in the amount of subretinal fluid (decrease, increase, and finally stable decrease), with a reduction in the CNV and the appearance of a subretinal band of hyperreflective tissue. The second group (4 eyes) showed little or no changes in retinal thickness, fluid, or reflectivity.

Conclusion

Changes observed in OCT3 scans represent variations in retinal thickness, fluid, and CNV after PDT. OCT3 provides a useful tool in the follow-up and measurement of changes appeared in eyes with CNV associated to AMD after treatment with PDT.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1.
Fig. 2.

Similar content being viewed by others

References

  1. Chauhan DS, Marshall J (1999) The interpretation of optical coherence tomography images of the retina. Invest Ophthal Vis Sci 40:2332–2342

    CAS  PubMed  Google Scholar 

  2. Hamada S, Yoshida K, Chihara E (2000) Optical coherence tomography changes of Retinitis Pigmentosa. Ophthalmic Surg Lasers 31:248–252

    PubMed  Google Scholar 

  3. Hee M, Baumal C, Puliafito C et al. (1996) Optical coherence tomography of age-related macular degeneration and choroidal neovascularization. Ophthalmology 103:1260–1270

    CAS  PubMed  Google Scholar 

  4. Hee M, Izatt J, Swanson E et al. (1995) Optical coherence tomography of the human retina. Arch Ophthalmol 113:325–332

    CAS  PubMed  Google Scholar 

  5. Hee M, Puliafito C, Wong C et al. (1995) Quantitative asessment of macular edema with optical coherence tomography. Arch Ophthalmol 113:1019–1029

    CAS  PubMed  Google Scholar 

  6. Huang D, Swanson E (1991) Optical coherence tomography. Science 254:1178–1181

    Google Scholar 

  7. Klein R, Klein BEK, Linton KLP (1992) Prevalence of age-related maculopathy: the Beaver Dam eye study. Ophthalmology 99:933–943

    Google Scholar 

  8. Konno S, Akiba J, Yoshida A (2001) Retinal thickness measurements with optical coherence tomography and the scanning retinal thickness analyzer. Retina 21:57–61

    CAS  PubMed  Google Scholar 

  9. Michels S, Schmidt-Erfurth U (2003) Sequence of early vascular events after photodynamic therapy. Invest Ophthalmol Vis Sci 44:2147–2154

    Article  PubMed  Google Scholar 

  10. Miller J, Schmidt-Erfurth U, Sickenberg M et al. (1999) Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of a single treatment in a phase 1 and 2 study. Arch Ophthalmol 117:1161–1173

    CAS  PubMed  Google Scholar 

  11. Moshfeghi DM, Kaiser PK, Grossniklaus HE et al. (2003) Clinicopathologic study after submacular removal of choroidal neovascular membranes treated with verteporfin ocular photodynamic therapy. Am J Ophthalmol 135: 343–350

    Article  CAS  PubMed  Google Scholar 

  12. Tan W, Beaumont PE, Chang AA (2003) Case series outcomes at 1 week following verteporfin photodynamic therapy. Retina 23:166–170

    PubMed  Google Scholar 

  13. Rogers AH, Martidis A, Greenberg PB, Puliafito C (2002) Optical coherence tomography findings following photodynamic therapy of choroidal neovascularization. Am J Ophthalmol 134:566–576

    Article  PubMed  Google Scholar 

  14. Treatment of age-related macular degeneration with photodynamic therapy (TAP) study group (1999) Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin. One-year results of 2 randomized clinical trials: TAP report 1. Arch Ophthalmol 117:1329–1345

    PubMed  Google Scholar 

  15. Treatment of age-related macular degeneration with photodynamic therapy (TAP) study group (2001) Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin. Two-year results of 2 randomized clinical trials: TAP report 2. Arch Ophthalmol 119:198–207

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to José M. Ruiz-Moreno.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Montero, J.A., Ruiz-Moreno, J.M. & Tavolato, M. Follow-up of age-related macular degeneration patients treated by photodynamic therapy with optical coherence tomography 3. Graefe's Arch Clin Exp Ophthalmol 241, 797–802 (2003). https://doi.org/10.1007/s00417-003-0752-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-003-0752-3

Keywords

Navigation